Ambulatory Care Growth METRO INFECTIOUS DISEASE CONSULTANTS operates as a state-of-the-art ambulatory care provider with outpatient antibiotic therapy and biological infusion services, presenting a clear opportunity to expand partnerships with outpatient networks, infusion centers, and ancillary services to increase patient throughput and reduce hospitalizations.

Hospital Avoidance Program Their Hospital Avoidance Program offers same-day rapid evaluation and treatment for acute infections, signaling potential collaboration with urgent care centers, ERs, and primary care groups to shift appropriate cases from inpatient to outpatient management, driving volume and cost-efficiency.

Insurance Coordination A dedicated capability to verify insurance coverage, coordinate benefits, and schedule initial and follow-up visits suggests value in partnerships with payer networks, patient access teams, and hospital systems aiming to streamline reimbursement and reduce appointment no-shows.

Strategic Partnerships Recent collaboration with Benedictine University to open a vaccination clinic demonstrates openness to academic and community partnerships, presenting a pathway to co-branded programs, continuing education opportunities, and expanded vaccination or infection prevention services.

Revenue Scale With reported revenue in the range of fifty to one hundred million dollars and a sizable workforce, MIDC represents a mid-to-large scale partner for enterprise health initiatives, clinical outsourcing, and infection disease management programs within hospital systems and large employer health plans.